PharmaBlock Sciences Nanjing Inc
SZSE:300725
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Price:
38.17
CNY
-4.98%
Market Closed
Market Cap:
¥8.9B
Relative Value
The Relative Value of one
PharmaBlock Sciences Nanjing Inc
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 38.17 CNY,
PharmaBlock Sciences Nanjing Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PharmaBlock Sciences Nanjing Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
PharmaBlock Sciences Nanjing Inc Competitors
PharmaBlock Sciences Nanjing Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
PharmaBlock Sciences Nanjing Inc
SZSE:300725
|
8.9B CNY | 4.5 | 44.4 | 35.5 | 35.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
951.3B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
595.7B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF | 4.6 | 29.9 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF | 5.6 | 22.4 | 13.8 | 17.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.2B GBP | 5.3 | 30.4 | 16.8 | 23.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.5B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.5B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
